Table 3.

Treatment-related characteristics of T2DM respondents treated with insulin therapy (n = 249)

Variables	Frequency (%)		P-value*
	Adherence n = 21	Non-adherence n = 228
Number of concomitant medications†	6.3 (1.3)	6.5 (1.9)	0.695
Duration of use of insulin therapy†	4.1 (3.8)	3.1 (2.4)	0.110
Type of insulin
Prandial	1 (4.8)	13 (5.7)
Basal	2 (9.5)	89 (39.0)	0.329
Pre-mixed	10 (47.6)	44 (19.3)	0.323
Combination	8 (38.1)	82 (36.0)	0.829
Number of daily insulin injections†	2.7 (1.2)	2.0 (1.1)	0.014
Total daily dosage of insulin (IU)†	52.6 (28.6)	41.4 (28.6)	0.093
Self-injection of insulin
No	0 (0.0)	15 (6.6)
Yes	21 (100.0)	213 (93.4)	0.623
Preference of oral therapy
No	17 (80.9)	144 (63.2)
Yes	4 (19.1)	38 (36.8)	0.113
Fear of injection
No	20 (95.2)	193 (84.6)
Yes	1 (4.8)	35 (15.4)	0.216
Use of TCM
No	14 (66.7)	192 (84.2)
Yes	7 (33.3)	36 (15.8)	0.049
Experience insulin’s side effect
No	19 (90.5)	201 (88.2)
Yes	2 (9.5)	27 (11.8)	0.752
SMBG
No	2 (9.5)	89 (39.0)
Yes	19 (90.5)	139 (61.0)	0.017
Attended MTAC
No	20 (95.2)	213 (93.4)
Yes	1 (4.8)	15 (6.6)	0.746

Notes:

^*simple logistic regression;

^†mean (SD)